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Background: Thyroid autoimmunity was thought to be rare in Africans but there is evidence that its prevalence is increasing.
Since undetected autoimmune thyroid disease carries considerable morbidity, this study set out to determine the proportion of
patients with goitre who have thyroid autoantibodies and the relationship, if any, between the presence of thyroid
autoantibodies, thyroid function and thyroid size.
Methods: The study was cross-sectional and conducted over a 12-month period. It involved 100 subjects with goitre and 50
apparently healthy controls without goitre, matched for age and sex. Thyroid dysfunction was assessed by history, clinical
examination and biochemical tests, thyroid peroxidase and thyroglobulin antibodies. The size of the thyroid gland was
assessed by ultrasound.
Results: Fifty-sevenpercent (57%) of study subjects were euthyroid, 38%werehyperthyroid, while 2%were hypothyroid. The overall
prevalence of elevated thyroid peroxidase antibody (TPOAb) in the subjects with goitre was 35% and 8% in the controls (p < 0.001).
Elevated thyroglobulin antibody (TgAb) was found in 24% of subjects with goitre and 12% of controls (p = 0.083). Elevated TPOAb
was found in 76.3% of subjects who were hyperthyroid, 7% of subjects who were euthyroid and 100% of subjects who were
hypothyroid (p < 0.001). Elevated TgAb level was present in 36.8%, 15.8% and 50% of subjects with hyperthyroid, euthyroid and
hypothyroid goitre respectively (p = 0.068). A positive correlation was observed between TPOAb and erythrocyte sedimentation
rate (r = 0.582, p < 0.001) and TgAb and erythrocyte sedimentation rate (r = 0.176, p = 0.08). The correlation between TPOAb and
thyroid volume (r = –0.139, p = 0.167) and that of TgAb and thyroid volume (r = –0.119, p = 0.238) was not significant.
Conclusion: The prevalence of thyroid autoantibodies in patients with goitre is high in Nigeria. Thyroid peroxidase antibody is more
prevalent than thyroglobulin antibody in thyroid disorders and appears to be a better marker than thyroglobulin antibody in
detecting autoimmune thyroid dysfunction.
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Introduction
Thyroid disorders are the second most common endocrine dis-
order in Nigeria after diabetesmellitus.1 TheWorld Health Organ-
ization (WHO) classified 7% of the world population as suffering
from clinically apparent goitre.2 Most patients are in developing
countries, where the disease is attributed to iodine deficiency.3
Endocrine disease of the thyroid may result in either under- or
over-activity of the gland. This may be due to congenital
factors, inadequate levels of dietary iodine intake, pregnancy,
radiotherapy, viral infection, surgery, underlying disease such
as infiltrative disorders or autoimmunity.4–6
The classic autoimmune thyroid disorders, Graves’ disease (GD)
and Hashimoto’s thyroiditis (HT), are characterised by the pres-
ence of elevated levels of serum antibodies directed against
thyroid antigens, namely thyroglobulin antibody (TgAb) and
thyroid peroxidase antibody (TPOAb).7 Other autoantibodies in
autoimmune thyroid disorders include thyroid stimulating
hormone receptor antibody, which is specific for Graves’ disease
and antibody to sodium iodide symporter, which currently has
no demonstrable diagnostic role in thyroid autoimmunity.7
In a study carried out by Olusi et al.8 4.6% of patients with goitre
were found to have significantly positive autoantibody titres
against thyroglobulin (Tg) while none of the 59 normal controls
matched for age and sex had demonstrable autoantibodies.
Isichei et al.,9 in a survey of endemic goitre in Jos, showed that
goitre is highly endemic in the area with prevalence varying
from 1% to 23%. Females showed a markedly higher prevalence
of goitre. Though urine samples indicated that iodine excretion
was similar to that in iodine-deficient areas of the world, no
relationship was observed between the prevalence of goitre
and urinary iodine. It could therefore not be concluded that the
aetiology of endemic goitre in this area was associated with
iodine deficiency. It was thus concluded that endemic goitre
may be an interplay of multiple factors of aetiological importance.
Okosieme et al.,10 in a study on the prevalence of thyroid anti-
bodies in Nigerian patients, found that TgAb and TPOAb were
found in 4% and 7%, respectively, of healthy adult controls,
11.6% and 76.8% of patients with GD, 25% and 12.5% of patients
with toxic nodular goitre (TNG) and 9.52% and 14.29% of patients
with simple non-toxic goitre (SNTG). The prevalence of thyroid
autoantibodies found by Okosieme et al.10 was higher than that
reported in previous studies in Africans.11,12 This may be due to
the use of agglutination method in previous studies, a less sensi-
tive method compared with enzyme-linked immunosorbent
assay (ELISA), which was used by Okosieme et al.
Autoimmune thyroid disease (AITD) is a common organ-specific
autoimmune disorder resulting in dysfunction of the thyroid
gland. AITD includes chronic autoimmune thyroiditis or
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Hashimoto’s thyroiditis (HT) and its variants (painless postpar-
tum and sporadic thyroiditis), autoimmune atrophic thyroiditis
or primary myxoedema and Graves’ disease (GD). Genetic and
environmental factors appear to interact, leading to the for-
mation of autoantigens and accumulation of antigen-presenting
cells (APCs) in the thyroid. Due to loss of immune tolerance,
autoreactive immune cells activated by APCs invade the
thyroid gland, interacting with thyroid cells.
Hashimoto’s thyroiditis and atrophic thyroiditis are differen-
tiated from each other based on clinical findings. Hashimoto’s
thyroiditis is characterised by the presence of goitre, thyroid
autoantibodies against thyroid peroxidase and thyroglobulin
in the serum and varying degrees of thyroid dysfunction. It
results from immune response, which leads to infiltration of
autoantigen-specific lymphoid cells and destruction of thyroid
follicles. The intrathyroidal lymphocytes are both T and B lym-
phocytes, with predominant Th-1 subtype. The overall effect is
hypothyroidism due to destruction of thyroid cells. Atrophic thy-
roiditis is characterised by a small thyroid gland with lymphocy-
tic infiltration and replacement of normal thyroid parenchyma
by fibrous tissue. It presents with clinical hypothyroidism.
Graves’ disease is characterised by follicular hyperplasia,
patchy lymphocytic infiltration of the thyroid and occasional for-
mation of lymphoid germinal centres.
The predominant thyroid-infiltrating T lymphocytes act mainly
as CD4+ Th2 cells. Graves’ disease is due to antibodies to the
thyroid stimulating hormone receptor (TSHR), which stimulate
thyroid growth and function.
Autoimmune diseases of the thyroid gland are polygenic dis-
orders resulting from the combination of a genetic predisposi-
tion and an environmental trigger. Genetic factors are
predominant, accounting for 80%, and environmental factors,
accounting for 20%, of susceptibility to develop autoimmune
thyroid disease.
Environmental factors implicated in the development of auto-
immune diseases include iodine, drugs like amiodarone, inter-
feron-α, interleukin-2, highly active antiretroviral therapy,
infectious organisms, cigarette smoking, selenium intake, stress-
ful events, external and internal radiation. Antibodies produced
in response to certain infectious agents like Yersinia
enterocolitica react with human cell proteins, due to their struc-
tural resemblance. Other precipitating or predisposing factors
include sex steroids and trauma.
Iodine is an important environmental agent known to increase
the risk of thyroid autoimmunity. Studies support a role for
iodine in the initiation and promotion of autoimmune thyroid
disease. Studies have shown that the appearance of thyroid
autoantibodies has been associated with iodination of salt in
iodine-deficient areas.13,14 Several mechanisms have been pro-
posed for the induction of thyroid autoimmunity by excess
iodine. Iodination of thyroglobulin increases its immunogenicity
by altering its stereochemical structure, leading to the pro-
duction of iodine-containing determinants and the loss of
some and appearance of other hidden epitopes. These may
enhance the presentation of thyroglobulin by antigen present-
ing cells and increase the affinity of the T lymphocyte receptor
(TCR) for the thyroglobulin, leading to specific T lymphocyte acti-
vation. Another mechanism is toxic destruction of thyroid cells
through the generation of oxygen radicals. Excessive amounts
of the iodide ion are oxidised by thyroid peroxidase producing
large amounts of oxidative intermediates and these molecules
are capable of oxidising membrane lipids and proteins, thus
damaging thyroid cell membranes. Iodine also has direct stimu-
lation effects on macrophages, dendritic cells, and B and T lym-
phocytes. Enhanced macrophage myeloperoxidase activity,
augmentation of dendritic cell maturation, increase in the
number of circulating T lymphocytes and stimulation of immu-
noglobulin production are some of the possible iodine effects
on the immune system.15
Three main thyroid autoantigens are involved in AITD. These are
thyroid peroxidase (TPO), thyroglobulin (Tg) and TSH receptor.
Other autoantigens, such as the sodium/iodide symporter (NIS)
have also been described but are of unknown significance at
this time.16
To date, studies on the prevalence of thyroid autoantibodies in
patients with goitre in Nigeria remain sparse. Since undiagnosed
thyroid diseases and autoimmunity carry considerable morbid-
ity, it is imperative to study the relationship between thyroid
function, thyroid size and thyroid autoantibodies in Nigerians.
This study therefore tested the hypothesis that there is no
relationship between thyroid autoantibodies and thyroid
function.
Methodology
The study was conducted at the Obafemi Awolowo University
Teaching Hospital Complex (OAUTHC). The study population
included all patients who were 18 years and above, who pre-
sented with goitre within the study period to both the
medical and surgical outpatient units of OAUTHC. It was a
cross-sectional study. A data proforma was used to document
demographic data and clinical parameters. The presence of
thyrotoxicosis and hypothyroidism was determined through
interviews, physical examination and laboratory findings. This
study was conducted over a period of one year. The sample
size was calculated using Fisher’s formula.17 The calculated
sample size was 96; however, 100 patients were recruited for
the study. Fifty apparently healthy subjects without goitre who
gave their consent served as controls. Consecutive patients
who presented with goitre within the study period and met
the inclusion criteria were recruited and examined. Approval
of the Ethics and Research committee of the Obafemi
Awolowo University Teaching Hospital Complex was obtained
for the study. Informed consent was obtained from each
patient and healthy controls after a discussion session in the
patient’s best understood language.
Patients with goitre who were aged 18 years and above, treat-
ment naive and ambulant were recruited. The exclusion criteria
included unwillingness to participate in the study, pregnant
women, patients on steroids, patients younger than 18 years,
patients presenting with a febrile illness, patients diagnosed
with cancer or on treatment for cancer, and patients known to
have connective tissue disease.
Enzyme immunoassay test kits (Cusabio Biotech Company Ltd,
Houston, TX, USA) were used for free thyronine (FT3), free thyr-
oxine (FT4), sensitive thyroid stimulating hormone (sTSH),
TPOAb and TgAb. Before proceeding with assays, all reagents,
sera references for this study and controls were brought to
room temperature. Test samples were serum type collected in
batches and stored frozen at −20 degrees Celsius without
repeated thawing and re-freezing. All assays were performed
on a fully automated ELISA Microwell ChemWell 2910 auto-
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analyzer (Awareness Technology Inc, Palm City, FL, USA) and in
duplicate.
Participants were placed into three groups (Table 1) according to
symptoms and biochemical profile. Group I: patients who had
goitre and symptoms suggestive of hypothyroidism such as
cold intolerance, weight gain, constipation and supporting bio-
chemical findings of low FT3, low FT4 and elevated sTSH were
classified as hypothyroid. Group II: patients who had goitre
and symptoms suggestive of thyrotoxicosis such as heat intoler-
ance, weight loss, hyperdefecation and supporting biochemical
findings of elevated FT4 and/or elevated FT3 and low sTSH were
classified as hyperthyroid. Group III: patients who had goitre but
without symptoms suggestive of hypothyroidism or thyrotoxi-
cosis and normal FT3, FT4 and sTSH were classified as euthyroid.
Normal range for FT3 was 1.4–4.2 pg/ml, normal range for FT4
was 0.8–2.0 ng/dl, normal range for sTSH was 0.5–5.6 UIU/ml,
elevated TPOAb was defined as level > 40 IU/ml while elevated
TgAb was defined as level > 125 IU/ml.
Data were entered and analysed using the Statistical Package for
the Social Sciences (SPSS) version 17 (SPSS Inc, Chicago, IL, USA).
The prevalence of thyroid autoantibodies in patients with goitre
was determined using percentages. Descriptive analyses were
presented with frequency tables, charts and graphs as appropri-
ate. Association between qualitative variables was determined
using chi-square analysis. Comparison of means was by
Student’s t-test when two groups were considered and analysis
of variance (ANOVA) was used whenmore than two groups were
involved. Mann–Whitney U and Kruskal–Wallis H tests were used
for skewed data. Correlation of means between groups was
assessed using Pearson’s correlation coefficient. The level of stat-
istical significance was set at p < 0.05.
Results
A total of 150 subjects participated in the study. This comprised
100 subjects with goitre and 50 apparently healthy subjects
without goitre. Characteristics of the study population are
given in Table 2. The age range for the subjects with goitre
was 18–70 years while that of the controls was 22–65 years.
The mean (±SD) age for subjects with goitre was 44.6 ± 13.8
years while that of the controls was 43.5 ± 16.7 years (p =
0.681, t = 0.412).
Male subjects accounted for 17 (11.3%) of the overall population
studied while 133 (88.7%) subjects were female. Among the sub-
jects with goitre, 12 (12%) were male while 88 (88%) were female
giving a female to male ratio of 7.3:1. Among the control group,
5 (10%) were male and 45 (90%) were female. There was no stat-
istical difference in the sex distribution of the subjects with
goitre and the controls (p = 0.716, χ2 = 0.133).
Eighty-six (86%) subjects with goitre used iodised salt in their
food while all the subjects in the control group ingested
iodised salt. Some 14% of the subjects with goitre had a
family history of a similar neck swelling while only 7% of them
had a history of a similar neck swelling in their neighbourhood.
None of the subjects in the control group reported a history of
anterior neck swelling in members of their family or in their
neighbourhood.
The mean (±SD) duration of neck swelling in subjects with goitre
was 34.0 ± 48.9 months. Based on the history and clinical exam-
ination findings, 60% (60) of the subjects with goitre were
euthyroid, 38% (38) were hyperthyroid, while only 2% (2) were
hypothyroid. Of the subjects with hyperthyroidism, 18 (47.4%)
subjects had Graves’ disease clinically.
The frequency of reported symptoms of thyrotoxicosis is given
in Table 3. Symptoms most commonly reported by subjects
with hyperthyroid goitre were: excessive sweating 38 (100%)
and weight loss 38 (100%). Palpitations were reported in 33
(86.8%), hyperdefecation in 30 (78.9%) and heat intolerance in
28 (73.7%). The 2 (100%) subjects with hypothyroidism reported
symptoms of constipation, cold intolerance and weight gain.
The mean ± standard deviation (SD) pulse rate in subjects with
goitre was 90.1 ± 14.9 bpm while that of the control group
was 79.2 ± 8.4 bpm (p < 0.001). The mean (± SD) pulse rate in
subjects with hypothyroidism was 79.0 ± 12.7 bpm, in subjects
with euthyroidism 79.6 ± 8.3 bpm and in subjects with
hyperthyroidism 106.3 ± 5.9 bpm (p < 0.001).
The mean systolic blood pressure (±SD) in subjects
with hypothyroidism, euthyroidism and hyperthyroidism was
111.0 ± 1.4 mmHg, 122.8 ± 13.1 mmHg and 137 ± 19.3 mmHg
respectively (p < 0.001) while the mean diastolic blood
Table 1: Definition of subjects with goitre
Groups Symptoms Biochemical profile
I: Hypo Symptoms of hypothyroidism Low FT3
Low FT4
Elevated sTSH









Hypo = hypothyroidism, Hyper = hyperthyroidism, Euthy = euthyroidism, FT3= free
triiodothyronine, FT4= free thyroxine, sTSH = sensitive thyroid stimulating hormone.






Mean age ± SD (Years) 44.6 ± 13.8 43.5 ± 16.7 0.681
Gender:
Female 88 (88) 45 (90) 0.716
Male 12 (12) 5 (10)
IID 86 (86) 50 (100) 0.021
FHG 14 (14) – 0.005
HGN 7 (7) – 0.096
SD = standard deviation, IID = ingestion of iodized salt, FHG = family history of
goitre, HGN = history of goitre in neighbourhood.




Excessive sweating 38 (100%)
Weight loss 38 (100%)
Palpitation 33 (86.8%)
Hyperdefecation 30 (78.9%)
Heat intolerance 28 (73.7%)
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pressure ± SD in hypothyroid, euthyroid and hyperthyroid
goitres was 65.0 ± 7.1 mmHg, 71.5 ± 9.1 mmHg and 69.7 ±
10.9 mmHg respectively (p = 0.853). The mean systolic and dias-
tolic blood pressure for the control group were 112.1 ± 9.3
mmHg and 66.9 ± 5.9 mmHg respectively.
The results of intra-assay and inter-assay precision for thyroid
function tests and thyroid autoantibodies are given in Table 4.
The coefficients of variation were within acceptable limits.
Elevated TPOAb was found in 35 (35%) subjects with goitre and
4 (8%) of the control group (p < 0.001), and elevated TgAb was
found in 24 (24%) subjects with goitre and 6 (12%) subjects
without goitre. Table 5 compares the prevalence of thyroid auto-
antibodies between subjects with goitre and the control group.
The mean TPOAb ± SD in the subjects with goitre was 128.1 ±
204.6 IU/ml while that of the control group was 38.6 ±
104.7 IU/ml (p = 0.001). The mean TgAb ± SD in the subjects
with goitre was 109.3 ± 112.3 while that of the control group
was 73.7 ± 53.1 IU/ml (p = 0.035). Table 6 shows the prevalence
of thyroid autoantibodies among the various groups with
goitre. The median concentrations of TPOAb in subjects with
hypothyroidism, hyperthyroidism and euthyroidism were
273.1, 229.5 and 101.5 IU/ml respectively, while the median
levels of TgAb were 124.7, 113.9 and 64.2 IU/ml, respectively.
Discussion
The mean (±SD) age of occurrence of goitre in this study was
44.6 ± 13.8 years. This is similar to the mean age observed in
earlier studies of thyroid disorders by Ogbera et al.1 in Lagos,
Kolawole18 in Ile-Ife and Chehade et al.19 in the United States,
who found a mean age of 40 ± 12.4 years, 42.7 ± 12.6 years
and 47.8 ± 14.9 years respectively. Most of the subjects with
goitre were female with a female to male ratio of 7.3:1. This is
also similar to the female to male ratio observed from other
studies in this environment.1,18,20,21 Female preponderance is
expected in this study as thyroid disorders occur more com-
monly in females compared with males. Being female carries a
10–20-fold risk of developing autoimmune disease compared
with being male. This association does not apply only to auto-
immune thyroid disease but also applies to the development
of multinodular goitre and differentiated thyroid carcinoma
but not undifferentiated thyroid carcinoma.22 The mechanism
of this is not clear, but it has been suggested that females gen-
erally have greater reactivity of the thyroid gland, or subject it
more to greater stress. It has been suggested that there may
be specific receptors on the promoter for human leukocyte
antigen-D related (HLA-DR) genes that make them responsive
to the oestrogen receptor.22
The two most common symptoms of hyperthyroidism observed
in this study were excessive sweating and weight loss. These
symptoms were among the five most common symptoms
reported by Ogbera et al.1 In a study of 44 Nigerians with thyro-
toxicosis, Famuyiwa and Bella23 also observed similar features
but weight loss and palpitations appeared to be the two most
frequent symptoms. The frequency of symptoms of thyrotoxi-
cosis reported in this study are comparable to those reported
in Caucasians.19,24
Elevated thyroid peroxidase antibody (TPOAb) was found in 35%
of subjects with goitre but only in 8% of the control group (p <
0.001). These findings agree with the report by Okosieme et al.10
in a study of the prevalence of thyroid autoantibodies in
Nigerian patients. These findings were also comparable to
those of AL-Naqdy et al.25 and Kuria and Amayo,26 who reported
prevalence rates of 39% and 51.4% respectively. A higher preva-
lence of 89% was found by Shinto et al.,27 who studied subjects
with histologically proven autoimmune thyroid disease. In this
study, TPOAb was elevated in 76.7% of subjects with hyperthyr-
oid goitre. Chiyanga et al.12 and Hawa et al.,28 however, reported
a lower prevalence of 39% and 44% respectively in subjects with
hyperthyroidism. The higher prevalence of elevated TPOAb in
hyperthyroid subjects in this study could be due to the fact
that about half of these patients had Graves’ disease clinically.
All subjects with hypothyroid goitre had elevated TPOAb and
this result is comparable to the findings of Chaieb et al.29 The
prevalence of TPOAb observed in this study is higher than pre-
viously reported in Africans12,28,30 and this may reflect an
increase in the prevalence of autoimmune thyroid disorders.
There is strong evidence that the pattern of thyroid disorders
in a population is dependent on environmental iodine
intake.31 Iodine deficiency disorders abound in areas with
inadequate iodine intake while autoimmune thyroid disorders
are rare in iodine deficiency but become more prevalent with
transition to iodine sufficiency.32 In this study most of the sub-
jects with goitre ingested iodised salt and this may indicate tran-
sition to iodine sufficiency, and therefore increased prevalence
of autoimmune thyroid disorders.
Elevated thyroglobulin antibody (TgAb) was found in 24% of the
subjects with goitre and 12% of the control group. Okosieme
et al.10 also found a prevalence of 9.52–25% in the subjects
with goitre. The prevalence of TgAb found in this study was
also comparable to the prevalence of 36.1% reported by Kuria
and Amayo.26 Elevated TgAb was found in 36.8% of the subjects







FT3 (pg/ml) 5.47 7.77
FT4 (ng/dl) 3.25 6.01
sTSH (UIU/ml) 7.1 7.7
TPOAb (IU/ml) 4.6 5.8
TgAb (IU/ml) 4.2 4.7
FT3= free triiodothyronine, FT4= free thyroxine, sTSH = sensitive thyroid stimulating
hormone, TPOAb = thyroid peroxidase antibody, TgAb = thyroglobulin antibody.
Table 5: Comparison of the prevalence of thyroid autoantibodies






TPOAb 35 (35%) 4 (8%) < 0.001
TgAb 24 (24%) 6 (12%) 0.083
TPOAb = thyroid peroxidase antibody, TgAb = thyroglobulin antibody.
Table 6: Comparison of the prevalence of thyroid autoantibodies among








TPOAb 2 (100%) 4 (7%) 29 (76.3%) < 0.001
TgAb 1 (50%) 9 (15.8%) 14 (36.8%) 0.068
Hypo = hypothyroidism, Euthy = euthyroidism, Hyper = hyperthyroidism, TPOAb =
thyroid peroxidase antibody, TgAb = thyroglobulin antibody.
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The results of intra-assay and inter-assay precision for thyroid
function tests and thyroid autoantibodies are given in Table 4.
The coefficients of variation were within acceptable limits.
Elevated TPOAb was found in 35 (35%) subjects with goitre and
4 (8%) of the control group (p < 0.001), and elevated TgAb was
found in 24 (24%) subjects with goitre and 6 (12%) subjects
without goitre. Table 5 compares the prevalence of thyroid auto-
antibodies between subjects with goitre and the control group.
The mean TPOAb ± SD in the subjects with goitre was 128.1 ±
204.6 IU/ml while that of the control group was 38.6 ±
104.7 IU/ml (p = 0.001). The mean TgAb ± SD in the subjects
with goitre was 109.3 ± 112.3 while that of the control group
was 73.7 ± 53.1 IU/ml (p = 0.035). Table 6 shows the prevalence
of thyroid autoantibodies among the various groups with
goitre. The median concentrations of TPOAb in subjects with
hypothyroidism, hyperthyroidism and euthyroidism were
273.1, 229.5 and 101.5 IU/ml respectively, while the median
levels of TgAb were 124.7, 113.9 and 64.2 IU/ml, respectively.
Discussion
The mean (±SD) age of occurrence of goitre in this study was
44.6 ± 13.8 years. This is similar to the mean age observed in
earlier studies of thyroid disorders by Ogbera et al.1 in Lagos,
Kolawole18 in Ile-Ife and Chehade et al.19 in the United States,
who found a mean age of 40 ± 12.4 years, 42.7 ± 12.6 years
and 47.8 ± 14.9 years respectively. Most of the subjects with
goitre were female with a female to male ratio of 7.3:1. This is
also similar to the female to male ratio observed from other
studies in this environment.1,18,20,21 Female preponderance is
expected in this study as thyroid disorders occur more com-
monly in females compared with males. Being female carries a
10–20-fold risk of developing autoimmune disease compared
with being male. This association does not apply only to auto-
immune thyroid disease but also applies to the development
of multinodular goitre and differentiated thyroid carcinoma
but not undifferentiated thyroid carcinoma.22 The mechanism
of this is not clear, but it has been suggested that females gen-
erally have greater reactivity of the thyroid gland, or subject it
more to greater stress. It has been suggested that there may
be specific receptors on the promoter for human leukocyte
antigen-D related (HLA-DR) genes that make them responsive
to the oestrogen receptor.22
The two most common symptoms of hyperthyroidism observed
in this study were excessive sweating and weight loss. These
symptoms were among the five most common symptoms
reported by Ogbera et al.1 In a study of 44 Nigerians with thyro-
toxicosis, Famuyiwa and Bella23 also observed similar features
but weight loss and palpitations appeared to be the two most
frequent symptoms. The frequency of symptoms of thyrotoxi-
cosis reported in this study are comparable to those reported
in Caucasians.19,24
Elevated thyroid peroxidase antibody (TPOAb) was found in 35%
of subjects with goitre but only in 8% of the control group (p <
0.001). These findings agree with the report by Okosieme et al.10
in a study of the prevalence of thyroid autoantibodies in
Nigerian patients. These findings were also comparable to
those of AL-Naqdy et al.25 and Kuria and Amayo,26 who reported
prevalence rates of 39% and 51.4% respectively. A higher preva-
lence of 89% was found by Shinto et al.,27 who studied subjects
with histologically proven autoimmune thyroid disease. In this
study, TPOAb was elevated in 76.7% of subjects with hyperthyr-
oid goitre. Chiyanga et al.12 and Hawa et al.,28 however, reported
a lower prevalence of 39% and 44% respectively in subjects with
hyperthyroidism. The higher prevalence of elevated TPOAb in
hyperthyroid subjects in this study could be due to the fact
that about half of these patients had Graves’ disease clinically.
All subjects with hypothyroid goitre had elevated TPOAb and
this result is comparable to the findings of Chaieb et al.29 The
prevalence of TPOAb observed in this study is higher than pre-
viously reported in Africans12,28,30 and this may reflect an
increase in the prevalence of autoimmune thyroid disorders.
There is strong evidence that the pattern of thyroid disorders
in a population is dependent on environmental iodine
intake.31 Iodine deficiency disorders abound in areas with
inadequate iodine intake while autoimmune thyroid disorders
are rare in iodine deficiency but become more prevalent with
transition to iodine sufficiency.32 In this study most of the sub-
jects with goitre ingested iodised salt and this may indicate tran-
sition to iodine sufficiency, and therefore increased prevalence
of autoimmune thyroid disorders.
Elevated thyroglobulin antibody (TgAb) was found in 24% of the
subjects with goitre and 12% of the control group. Okosieme
et al.10 also found a prevalence of 9.52–25% in the subjects
with goitre. The prevalence of TgAb found in this study was
also comparable to the prevalence of 36.1% reported by Kuria
and Amayo.26 Elevated TgAb was found in 36.8% of the subjects







FT3 (pg/ml) 5.47 7.77
FT4 (ng/dl) 3.25 6.01
sTSH (UIU/ml) 7.1 7.7
TPOAb (IU/ml) 4.6 5.8
TgAb (IU/ml) 4.2 4.7
FT3= free triiodothyronine, FT4= free thyroxine, sTSH = sensitive thyroid stimulating
hormone, TPOAb = thyroid peroxidase antibody, TgAb = thyroglobulin antibody.
Table 5: Comparison of the prevalence of thyroid autoantibodies






TPOAb 35 (35%) 4 (8%) < 0.001
TgAb 24 (24%) 6 (12%) 0.083
TPOAb = thyroid peroxidase antibody, TgAb = thyroglobulin antibody.
Table 6: Comparison of the prevalence of thyroid autoantibodies among








TPOAb 2 (100%) 4 (7%) 29 (76.3%) < 0.001
TgAb 1 (50%) 9 (15.8%) 14 (36.8%) 0.068
Hypo = hypothyroidism, Euthy = euthyroidism, Hyper = hyperthyroidism, TPOAb =
thyroid peroxidase antibody, TgAb = thyroglobulin antibody.
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with hyperthyroidism, 50% of subjects with hypothyroidism and
15.8% of subjects with euthyroid goitre. Chiyanga et al.12 and
Kuria and Amayo26 also found a comparable prevalence of
39% and 33% respectively in subjects with thyrotoxicosis.
In this study, thyroid peroxidase antibodies were observed to be
more prevalent than thyroglobulin antibodies in subjects with
hypothyroidism and hyperthyroidism. This may reflect the fact
that TPOAb is a more specific test than TgAb for detecting auto-
immune thyroid diseases.
The mean TPOAb and TgAb were found to be significantly
higher in subjects with goitre when compared with the
control group (p = 0.001 and 0.035 respectively). Comparison
of the median levels of TPOAb and TgAb among subjects with
hypothyroidism, euthyroidism and hyperthyroidism was found
to be statistically significant only for TPOAb (p < 0.001 and p =
0.893 respectively). The median level of TPOAb was highest in
subjects with hypothyroidism, followed by hyperthyroidism
and euthyroidism. TPOAb was elevated in 100% of subjects
with hypothyroid goitre, but in 76.3% and 7% of subjects with
hyperthyroid and euthyroid goitre respectively. TPOAb thus
tends to be more commonly associated with thyroid dysfunction
of autoimmune origin than TgAb, and elevated TPOAb is mostly
associated with hypothyroidism. These findings are similar to
those previously reported by Okosieme et al.10 and other
authors.27,33,34 The findings in this study are in keeping with
the fact that high titres of TPOAb and TgAb are generally
found in patients with autoimmune thyroid diseases. These
more frequently occur in subjects with hypothyroidism com-
pared with hyperthyroidism and occasionally are found in
euthyroid goitres. Thyroid peroxidase antibody is found in up
to 95% of subjects with autoimmune hypothyroidism and in
70–80% of subjects with Graves’ disease, which commonly pre-
sents with hyperthyroidism. Thyroglobulin antibody also occurs
more frequently in subjects with autoimmune hypothyroidism
than in subjects with Graves’ disease.
Conclusions
The prevalence of thyroid autoantibodies in patients with goitre
in Nigeria is higher than previously reported. Thyroid peroxidase
antibody is more prevalent than thyroglobulin antibody in
thyroid disorders and it appears to be a better marker than
thyroglobulin antibody in detecting autoimmune thyroid dys-
function. In a resource-challenged setting where testing for
thyroid autoantibodies is expensive and not readily available,
screening for autoimmune thyroid dysfunction may be done
by testing for thyroid peroxidase antibody alone.
Disclosure statement – No potential conflict of interest was






1. Ogbera AO, Fasanmade O, Adediran O. Pattern of thyroid disorders in
the Southwestern Region of Nigeria. Ethn Dis. 2007;17:327–30.
2. Kally FC, Snedden WW. Prevalence and Geographical distribution of
endemic goitre. Bull World Health Organ. 1958;18:5–173.
3. Okosieme OE. Impact of iodination on thyroid pathology in Africa. J R
Soc Med. 2006;99:396–401.
4. Vanderpump MP, Tunbridge F. Epidemiology and prevention
of clinical and subclinical hypothyroidism. Thyroid.
2002;12:839–47.
5. Wiersinga WM. Sub clinical hypothyroidism and hyperthyroid-
ism. I.prevalence and clinical relevance. Neth J Med.
1995;46:197–204.
6. Brownlie BE, Wells JE. The epidemiology of thyrotoxicosis in New
Zealand: incidence and geographical distribution in north
Canterbury, 1983-1985. Clin Endocrinol. 1990;33:249–59.
7. Weetman AP, McGregor AM. Autoimmune thyroid disease: develop-
ments in our understanding. Endocr Rev. 1994;15:788–802.
8. Olusi SO, Ogunrin OA, Oluwole SF. Serum thyroglobulin autoanti-
body titres and immunoglobulin concentrations in Nigerians with
goitre. East Afr Med J. 1991;68:261–5.
9. Isichei UP, Morimoto I, Das SC, et al. Endemic goitre in the Jos Plateau
region of northern Nigeria. Endocr J. 1995;42:23–9.
10. Okosieme OE, Taylor RC, Ohwovoriole AE, et al. Prevalence of thyroid
antibodies in Nigerian patients. QJM. 2007;100:107–12.
11. Njemini R, Meyers I, Demanet C, et al. The prevalence of autoanti-
bodies in an elderly sub-Saharan African population. Clin Exp
Immunol. 2002;127:99–106.
12. Chinyanga EA, Benni A, Siziya S. Thyroid status and the levels of
thyroid auto- antibodies in the sera of hyperthyroid and goitrous
subjects. Cent Afr J Med. 2000;46:251–5.
13. Zois C, Stavrou I, Kalogera C, et al. High prevalence of autoimmune
thyroiditis in school children after elimination of iodine deficiency
in northwestern Greece. Thyroid. 2003;13:485–9.
14. Premawardhana LD, Parkes AB, Smyth PP, et al. Increased prevalence
of thyroglobulin antibodies in Sri Lankan schoolgirls—is iodine
cause? Eur J Endocrinol. 2000;143:185–8.
15. Luo Y, Kawashima A, Ishido Y, et al. Iodine excess as an environmental
risk Factor for autoimmune thyroid disease. Int J Mol Sci.
2014;15:12895–912.
16. Marcocci C, Chiovato L. Thyroid -directed antibodies. In: Thyroid BL,
editor. AU Williams and Wilkins. Philadelphia: Lippincott; 2000.
p. 414–31.
17. Araoye MO. Subjects Selection. In: Research Methodology with
Statistics for Social Sciences. 1st Edition. Ilorin: Nathadex
Publishers; 2004:115–29.
18. Kolawole BA. Study of Cardiovascular function in Thyrotoxic patients.
Part II Dissertation, West African College of Physicians 1999.
19. Chehade JM, Lim W, Silverberg AB, et al. The incidence of
Hashimoto’s disease in nodular goitre: the concordance in serologi-
cal and cytological findings. Int J Clin Pract. 2010;64:29–33.
20. Ikem R, Adebayo J, Soyoye D, et al. Spectrum of thyroid disorders in
Obafemi Awolowo University teaching hospital complex, Ile-Ife.
Presented at Society for Endocrinology BES 2010, Harrogate, UK.
Endocrine Abstracts 21 P366.
21. Ogbera AO. A two year audit of thyroid disorders in an urban hospital
in Nigeria. Nig Q Hosp Med. 2010;20:81–5.
22. De Groot LJ. Graves’ disease and the Manifestations of Thyrotoxicosis.
www.endotext.com 6:36pm 14/06/12.
23. Famuyiwa OO, Bella AF. Thyrotoxicosis in Nigeria: analysis of a five
year experience. Trop Geogr Med. 1990;42:248–54.
24. Boelaert K, Torlinska B, Holder RL, et al. Hyperthyroidism. Clin
Thyroidol. 2010;22:8–11.
25. AL-Naqdy A, Kutty I, AL- Harthi S, et al. Anti-thyroglobulin and Anti-
thyroid Microsomal Antibodies in thyroid disorders. Bahrain Med
Bull. 2003;25:1–8.
26. Kuria JG, Amayo A. Prevalence of antithyroid antibodies in
patients with primary thyroid disorders. East Afr Med J.
2008;85:459–62.
27. Shinto AS, Pachen L, Sreekanth TK, et al. Prevalence of Antithyroid
antibodies in histologically proven autoimmune thyroid diseases
and correlation with thyroid dysfunction in South India. Thyroid
Science. 2010;5:1–5.
28. Hawa MI, Picardi A, Constanza F, et al. Frequency of diabetes and
thyroid autoantibodies in patients with autoimmune endocrine
disease from Cameroon. Clin Immunol. 2006;118:229–32.
29. Chaieb L, Chaieb MC, Zebidi A, et al. Antithyroid antibodies. preva-
lence in primary hypothyroidism in Central Tunisia. Ann Endocrinol.
1991;52:331–3.
96 Journal of Endocrinology, Metabolism and Diabetes of South Africa 2019; 24(3):92–97
The page number in the footer is not for bibliographic referencingwww.tandfonline.com/oemd 34
30. Cardoso C, Ohwovoriole AE, Kuku SF. A study of thyroid function and
prevalence of thyroid autoantibodies in an African diabetic popu-
lation. J Diabetes Complications. 1995;9:37–41.
31. Laurberg P, Pedersen KM, Hreiderson A, et al. Iodine intake and the
pattern of thyroid disorders; a comparative epidemiological study
of thyroid abnormalities in the elderly in Iceland and in Jutland,
Denmark. J Clin Endocrinol Metab. 1998;83:765–9.
32. Doufas AG, Mastorakos G, Chatziioannou S, et al. The predominant
form of non toxic goitre in Greece is now thyroiditis. Eur Jcrinol.
1999;140:505–11.
33. Zelaya AS, Stott A, Nader S, et al. Antithyroid peroxidase antibodies in
patients with high normal range thyroid stimulating hormone. Fam
Med. 2010;42:111–5.
34. Hoogendoom EH, Hermus AR, Vegt F, et al. Thyroid function and
prevalence of Anti- thyroid peroxidase Antibodies in a population
with borderline Sufficient iodine intake; influences of Age and Sex.
Clin Chem. 2006;52:104–11.
Received: 16-01-2019 Accepted: 3-07-2019
Prevalence and clinical relevance of thyroid autoantibodies in patients with goitre in Nigeria 97
